The Potential of the Fibronectin Inhibitor Arg-Gly-Asp-Ser in the Development of Therapies for Glioblastoma
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25094910 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Maria L Castro-Ribeiro und 7 weiteren Autor:innen. Beteiligte Einrichtung: 3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Insti…. Hauptthemen laut MEDLINE: Glioblastoma, Doxorubicin, Oligopeptides, Fibronectins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Fundação para a Ciência e a Tecnologia (FCT), project Laboratório Associado ICVS/3B’s.
Abstract (Originalsprache)
Glioblastoma (GBM) is the most lethal and common malignant primary brain tumor in adults. An important feature that supports GBM aggressiveness is the unique composition of its extracellular matrix (ECM). Particularly, fibronectin plays an important role in cancer cell adhesion, differentiation, proliferation, and chemoresistance. Thus, herein, a hydrogel with mechanical properties compatible with the brain and the ability to disrupt the dynamic and reciprocal interaction between fibronectin and tumor cells was produced. High-molecular-weight hyaluronic acid (HMW-HA) functionalized with the inhibitory fibronectin peptide Arg-Gly-Asp-Ser (RGDS) was used to produce the polymeric matrix. Liposomes encapsulating doxorubicin (DOX) were also included in the hydrogel to kill GBM cells. The resulting hydrogel containing liposomes with therapeutic DOX concentrations presented rheological properties like a healthy brain. In vitro assays demonstrated that unmodified HMW-HA hydrogels only caused GBM cell killing after DOX incorporation. Conversely, RGDS-functionalized hydrogels displayed per se cytotoxicity. As GBM cells produce several proteolytic enzymes capable of disrupting the peptide–HA bond, we selected MMP-2 to illustrate this phenomenon. Therefore, RGDS internalization can induce GBM cell apoptosis. Importantly, RGDS-functionalized hydrogel incorporating DOX efficiently damaged GBM cells without affecting astrocyte viability, proving its safety. Overall, the results demonstrate the potential of the RGDS-functionalized hydrogel to develop safe and effective GBM treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Av…
- ICVS/3B's-PT Government Associate Laboratory, 4710-057/4805-017 Braga/Guimarães, Portugal.
- Life and Health Sciences Research Institute (ICVS), School of Medicine, Campus Gualtar, University of Minho, 4710-057 Braga, Portugal.
ORCID-Profile: Maria L Castro-Ribeiro, Vânia I B Castro, Ricardo A Pires, Rui L Reis, Bruno M Costa, Helena Ferreira, Nuno M Neves
Förderung
- Fundação para a Ciência e Tecnologia
- Fundação para a Ciência e a Tecnologia (FCT)
- project Laboratório Associado ICVS/3B’s
- project “TERM RES Hub—Scientific Infrastructure for Tissue Engineering and Regenerative Medicine”
- Northern Portugal Regional Coordination and Development Commission (CCDR-N)
Zitieren
APA
Castro-Ribeiro, M. L., Castro, V. I. B., Vieira de Castro, J., Pires, R. A., Reis, R. L., Costa, B. M., Ferreira, H., & Neves, N. M. (2024). The Potential of the Fibronectin Inhibitor Arg-Gly-Asp-Ser in the Development of Therapies for Glioblastoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094910
Vancouver
Castro-Ribeiro ML, Castro VIB, Vieira de Castro J, Pires RA, Reis RL, Costa BM, et al. The Potential of the Fibronectin Inhibitor Arg-Gly-Asp-Ser in the Development of Therapies for Glioblastoma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094910
BibTeX
@article{CastroRibeiro2024,
author = {Castro-Ribeiro, Maria L and Castro, Vânia I B and Vieira de Castro, Joana and Pires, Ricardo A and Reis, Rui L and Costa, Bruno M and Ferreira, Helena and Neves, Nuno M},
title = {The Potential of the Fibronectin Inhibitor Arg-Gly-Asp-Ser in the Development of Therapies for Glioblastoma},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25094910}
}
EUVIMED